Boston Scientific vs Edwards Lifesciences
Boston Scientific (BSX), health care, and Edwards Lifesciences (EW), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Boston Scientific and Edwards Lifesciences are valued at about the same: $62.6B and $61.8B. Boston Scientific trades at 18.2 times earnings and Edwards Lifesciences at 62.5; operating margins in their latest fiscal years were 18.0% and 20.8%. Over the past year Boston Scientific's share price has moved -56.0% and Edwards Lifesciences's +27.5%.
Key facts
- Boston Scientific market value
- $62.6B
- Edwards Lifesciences market value
- $61.8B
- Boston Scientific P/E
- 18.2
- Edwards Lifesciences P/E
- 62.5
- Boston Scientific revenue
- $20.1BFY to 2025-12-31
- Edwards Lifesciences revenue
- $6.1BFY to 2025-12-31
- Superinvestors holding both
- 2
Market values as of .
| Measure | Boston Scientific | Edwards Lifesciences |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size | ||
| Market cap | $62.6Bhigher | $61.8Blower |
| Revenue | $20.1Bhigher | $6.1Blower |
| Earnings | $2.9Bhigher | $1.1Blower |
| Employees | 59,000higher | 16,000lower |
| Total assets | $43.7Bhigher | $13.7Blower |
| Valuation | ||
| P/E | 18.2lower | 62.5higher |
| P/S | 3.1lower | 10.2higher |
| P/B | 2.4lower | 5.7higher |
| Dividend yield | 0.00% | 0.00% |
| Profitability | ||
| Operating margin | 18.0%lower | 20.8%higher |
| Balance sheet | ||
| Net assets | $24.2Bhigher | $10.3Blower |
| Total liabilities | $19.2Bhigher | $3.4Blower |
| Total debt | $11.4Bhigher | $598.3Mlower |
| Cash on hand | $2Blower | $2.9Bhigher |
| Price change | ||
| Today | -1.09%lower | +0.29%higher |
| 1 year | -56.0%lower | +27.5%higher |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (2)
- Primecap team1.6% / 0.2%
- Israel Englander0.1% / 0.2%
Boston Scientific only (11)
- Andrew Spokes2.6%
- Lee Ainslie2.3%
- Steven Romick1.2%
- Louis Bacon0.8%
- David Shaw (founder)0.7%
- John Overdeck and David Siegel (founders)0.6%
- Sarah Ketterer0.4%
- Dodge & Cox team0.3%
- Temasek0.3%
- Paul Tudor Jones0.3%
- Larry Robbins0.1%
Edwards Lifesciences only (7)
- David Rolfe3.1%
- Howard Gleicher1.6%
- Brandon Haley0.7%
- Steve Cohen0.2%
- Ken Griffin0.2%
- Baillie Gifford team0.1%
- Ron Baron0.1%
Percentages are each holding's share of that investor's reported portfolio (under "Both": Boston Scientific / Edwards Lifesciences). Who owns BSX · Who owns EW
More on Boston Scientific
Further comparisons
Boston Scientific against its closest peers
Edwards Lifesciences against its closest peers
Learn
Questions and answers
Which is bigger, Boston Scientific or Edwards Lifesciences?
By market value, Boston Scientific is the larger: $62.6B against $61.8B for Edwards Lifesciences. By revenue in its latest fiscal year, Boston Scientific is the larger: $20.1B against $6.1B for Edwards Lifesciences.
Which has the higher P/E ratio?
Edwards Lifesciences: 62.5, against 18.2 for Boston Scientific. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.
Which has the higher operating margin?
Edwards Lifesciences: 20.8%, against 18.0% for Boston Scientific. Operating margin is operating income as a share of revenue in the latest fiscal year.
Which has the higher dividend yield?
Neither: both stand at 0.00%. Dividend yield is the last twelve months' dividends as a share of today's share price.
Which has more debt?
Boston Scientific: $11.4B, against $598.3M for Edwards Lifesciences. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.
Which superinvestors own both Boston Scientific and Edwards Lifesciences?
In their latest 13F filings, Primecap team and Israel Englander hold both.
Cite this page
Funkfolio, “Boston Scientific vs Edwards Lifesciences”, data as of 17 November 2026. https://funkfolio.com/compare/bsx-vs-ew
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.